As of May 02
| -0.03 / -7.69%|
The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +1,288.89% increase from the last price of 0.36.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.